𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy

✍ Scribed by Martina Cesani; Alessia Capotondo; Tiziana Plati; Lucia Sergi Sergi; Francesca Fumagalli; Maria Grazia Roncarolo; Luigi Naldini; Giancarlo Comi; Maria Sessa; Alessandra Biffi


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
186 KB
Volume
30
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Metachromatic Leukodystrophy (MLD) is a rare inherited lysosomal storage disorder caused by the deficiency of Arylsulfatase A (ARSA). The disease manifests itself with a broad spectrum of clinical variants, all characterized by progressive neurodegeneration in the central and peripheral nervous systems. The correlation between mutations in the ARSA gene, residual enzymatic activity associated with the mutated alleles and patients' phenotype, which has been extensively drawn for common ARSA mutations, has recently been expanded to rare ones. In this context, functional studies on the rare allelic variances acquire particular relevance for patients' prognostic evaluation. Here we have characterized eight newly identified ARSA mutations, through lentiviral vector-based expression studies on cell lines and ARSA defective murine fibroblasts. In each case, the residual activity associated with the new mutant allele correlates well with the patient's phenotype. Therefore, our results confirm the importance of functional characterization of mutant alleles for a precise genotype-based classification and definition of prognosis in MLD patients, which is particularly relevant for pre-symptomatic diagnosis.


πŸ“œ SIMILAR VOLUMES


Identification of 12 novel mutations and
✍ Laura Gort; M. Josep Coll; Amparo ChabΓ‘s πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 2 views

Arylsulfatase A (ARSA) deficiency is the main cause of metachromatic leukodystrophy (MLD), a lysosomal disorder with no specific treatment. In view of the importance of genetic counseling, analyses of mutations and polymorphisms, including the ARSA pseudodeficiency allele, were carried out in 18 unr

Occurrence, distribution, and phenotype
✍ Berger, Johannes; LΓΆschl, Beate; Bernheimer, Hanno; Lugowska, Agnieszka; Tylki-S πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 2 views

Occurrence, distribution, and phenotype of arylsulfatase A (ASA) mutations were investigated in 27 patients with metachromatic leukodystrophy (MLD) from Central Europe, mainly from Austria (n = 15) and Poland (n = 9). Genomic DNA from leukocytes, fibroblasts, or paraffin-embedded, formalin-fixed bra

Identification of nine novel arylsulfata
✍ Barry Eng; Lisa N. Nakamura; Natasha O'Reilly; Natasha Schokman; Magorzata M.J. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 27 KB πŸ‘ 1 views

Metachromatic leukodystrophy (MLD) is a rare autosomal recessive disorder caused by mutations of the arylsulfatase A ( ARSA) gene. We have investigated more than fifty MLD patients using allele-specific PCR assays to detect the pseudodeficiency (PD) allele and several common MLD mutations, followed

Metachromatic leukodystrophy in the Nava
✍ N. M. Pastor-Soler; M. A. Rafi; J. D. Hoffman; D. Hu; D. A. Wenger πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 781 KB

Communicated by Robert I. Desnick Metachromatic leukodystmphy (MLD) is an autosomal recessive disorder of myelin metabolism, resulting from the inability to properly degrade 3-sulfogalactosylceramide (sulfatide). This metabolic block is often due to defective functioning of the lysosomal enzyme aryl

Metachromatic leukodystrophy: Identifica
✍ Ruxandra Draghia; Franck Letourneur; Cristina Drugan; Jeanne Manicom; Christophe πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 2 views

Metachromatic leukodystrophy (MLD), a lysosomal storage disease caused by the deficiency of arylsulfatase A (ASA), is inherited as an autosomal recessive trait, and its frequency is estimated to be 1 in 40,000 live births. Genomic DNA from 21 MLD patients (14 late-infantile and 7 juvenile cases) was